Patient info Open main menu

Indium (In111) Chloride – patient leaflet, side effects, dosage

Text from the MHRA, as of · About this document

Patient leaflet - Indium (In111) Chloride

1. What Indium In111 chloride is and what

it is used for

This medicine is for diagnostic use only.

Indium In111 chloride is used through a scan to examine different parts of your body, depending on the other non-radioactive component used. Your doctor will explain the purpose of use.

This medicine contains a radioactive substance which when mixed with the other component and administered, collects in certain organs.

The radioactive substance can be photographed from outside the body, using special cameras which take a scan. This scan shows the distribution of radioactivity within the organ and body. This also gives the doctor valuable information about the structure and function of that organ.

2. What you need to know b Indium In111

chloride is used

Do not use Indium In111 chloride

if you are

  • allergic to indium chloride or any of the other ingredients

    (listed in section 6).

Further information regarding when this medicine should not be used, is provided in the package leaflet of the other component.

Warnings and Precautions

This medicine does involve treatment with radioactivity. Your doctor will only give you this medicine if the benefit outweighs the risk.

Indium In111 chloride is given in one single dose by specialists, who will take responsibility for any necessary precautions.

Your doctor will inform you if you need to take any special precautions after using this medicine. Contact your doctor if you have any questions.

Other medicines and Indium In111 chloride

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Further information regarding medicines which can influence or be influenced by Indium In111 is provided in the package leaflet of the other component.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice.

  • Pregnancy and women of childbearing potential

    Your doctor will only administer Indium In111 chloride during pregnancy or when you might be pregnant if it is absolutely necessary, as it could harm the unborn child.

  • Breast-feeding

    He/she may delay treatment until breast-feeding is finished. He/she may also ask you to stop breast-feeding until the radioactivity is no longer in your body.

Driving and using machines

It is not investigated whether Indium In111 chloride impairs the ability to drive and operate machinery.

3. How Indium In111 chloride is used

Indium In111 chloride will always be used in a hospital or similar setting. It will only be administered to you by qualified people trained to safe handle radioactive material.

Your doctor will decide the Indium In111 chloride amount to be used. The dose administered depends on the medicine with which it is combined. The lowest dose possible will be used to produce adequate X-ray images

Children and adolescents

Lower doses may be used for children according to their weight, body surface area or age.

Method of use

The method of use depends on the substance with which it is combined.

If more Indium In111 chloride is administered than should

It is unlikely that overdose will occur as this medicine is given under control by a doctor.

However, if this happens you will receive appropriate treatment from your doctor.

If you have any further questions on the use of this product, ask your doctor.

DRN 4901 Indium (In111) Chloride United Kingdom Page 2 of 2

04901006BYS11a.docx / 24 APP 4901 United Kingdom SPC 15052019 / 26 APP 4901 United Kingdom PIL 15052019

4. Possible side effects

Like all medicines, Indium In111 chloride can cause side effects, although not everybody gets them.

This radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities.

Reporting of side effects

If you get any side effects, talk to your nuclear medicine doctor. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system:

Yellow Card Scheme

Website: www.mhra.gov.uk/yellowcard

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Indium In111 chloride

Do not use Indium In111 chloride after the expiry date stated on the label. Hospital staff will ensure correct storage temperature, below25°C as stated on the label. However, if more than one dose is intended for use, the vial should be stored between 2-8°C after the first dose is taken.

6. Contents of the pack and

otherinformation

What Indium In111 chloride contains

  • The active substance is 111In as indium chloride

    One millilitre of Indium In111 chloride contains 370 MBq.

  • The other ingredients are : hydrochloric acid, water for injections.

What Indium In111 chloride looks like and contents of the pack

Indium In111 chloride is packaged in type 1 Ph.Eur glass vials closed with a butyl rubber stopper and sealed with an aluminium crimp cap.

Pack sizes:

  • 111 MBq (0.3 ml)
  • 185 MBq (0,5ml)
  • 370 MBq (1.0 ml)
  • 555 MBq (1.5 ml)
  • 740 MBq (2.0 ml)

Marketing Authorisation Holder and Manufacturer

  • Marketing Authorisation Holder

    Curium Netherlands B.V., Westerduinweg 3

    1755 LE Petten, The Netherlands

    PL 12288/0004

  • Manufacturer

    Curium Netherlands B.V., Westerduinweg 3

    1755 LE Petten, The Netherlands

This leaflet was last approved in 05/2019

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 12288/0004

MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Indium (In111) Chloride

Pharmaceutical form Clear, colourless solution.
Excipients Hydrochloric acid, Water for injections
Shelf life The product expires 24 hours after activity reference date and time.
If multi-dose use is intended, each aliquot should be removed under aseptic conditions, and within one working day. The vial should be stored between 2°C - 8°C after removal of the first aliquot.
Storage Store below 25 °C.
For storage conditions after first opening of the medicinal product, see section 6.3.
Storage should be in accordance with national regulations for radioactive material.
Drug group (ATC) Diagnostic radiopharmaceuticals, tumour detection, Indium(111In) compounds
  1. V Various drug classes
    1. V09 Diagnostic radiopharmaceuticals
      1. V09I Tumour detection radiopharmaceuticals
        1. V09IB Indium-111 tumour detection radiopharmaceuticals
Marketing authorisation PL 12288/0004 (first authorised 15 May 2001)
Marketing authorisation holder Curium Netherlands B.V.

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.